Cardiovascular Drugs
Repurposing of approved cardiovascular drugs
... new drugs requires both long time and high costs, whereas safety and tolerability profiles make the success rate of approval very ...known drugs and compounds to new indications, has been noted recently as ...
15
<p>Is it possible to prevent chemotherapy-induced heart failure with cardiovascular drugs - the review of the current clinical evidence</p>
... Abstract: Cardiovascular diseases and cancer are the most common death causes in the USA and ...cardiotoxic drugs and introducing potential cardioprotective agents to the ...of cardiovascular ...
16
Compatibility of Terminalia arjuna (Roxb.) Wight & Arn. with common cardiovascular drugs
... After preliminary observation with serial dilution of T. arjuna, cardiovascular drugs and mixture of drugs, (62.5 µg/ml and 100 µg/ ml), dissolved in water, dilute HCl (p H 2.5), dilute NaOH (p H ...
5
Development of validated analytical methods for selected Cardiovascular Drugs in formulations and its application in in-vitro interaction studies.
... Reference standards used in the study were having HPLC purity >99% of dronedarone hydrochloride, rivaroxaban, levosimendan, ticagrelor, aspirin, clopidogrel and atorvastatin were purchased from reputed suppliers with ...
276
PHARMACOLOGY EFFECT OF CARDIOVASCULAR DRUGS ON THE LEVEL OF THYROID HORMONES AND VITAMIN-D.
... vein thrombosis and pulmonary embolism etc. By 2030, almost 25 million people will die from CVDs, mainly from heart disease and stroke. These are projected to remain the single leading cause of death, 51% of deaths due ...
5
Feasibility of cardiovascular drugs to transdermal delivery: Prediction of plasma levels using a pharmacokinetic model
... of drugs has become the viable and successful dosage form due to its clinical ...of cardiovascular drugs to transdermal delivery, a pharmacokinetic approach to predict plasma drug levels was ...the ...
5
Danish register-based study on the association between specific cardiovascular drugs and fragility fractures
... A major strength of this study is the large population, which allowed us to examine the association between fractures and exposure to speci fi c cardiovascular drugs. However, it is an observational study, ...
9
EVALUATION OF ADVERSE EFFECTS DUE TO ANTIDIABETIC AND CARDIOVASCULAR DRUGS IN A TERTIARY CARE HOSPITAL IN KOLKATA, WEST BENGAL, INDIA
... hypertension, cardiovascular diseases, etc. A number of drugs are available to handle these health problems ...of drugs or ...and cardiovascular drugs were collected and ...and ...
6
A NOVEL RP HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF CARDIOVASCULAR DRUGS IN A POLYCAP FORMULATION
... A new, simple and rapid RP-HPLC method has been developed and validated for the simultaneous estimation of Aspirin, Atenolol, HCTZ, Ramipril and Simvastatin. The method is accurate, specific, precise and robust. The ...
11
Adverse Drug Reactions of Cardiovascular Drugs in Intensive Cardiac Care Unit in a Tertiary Care Hospital: A Prospective Study
... This was a prospective observational study carried out at the intensive cardiac care unit, medicine department, Sree Balaji Medical College and Hospital, Chennai. Institutional Research Committee and Human Ethics ...
5
Drug utilization evaluation of cardiovascular drugs in outpatient department in a tertiary care hospital: a descriptive observational study
... The most common risk factors (both in rural and urban) based on the frequency of occurrence in the present study are Age, Hypertension, Smoking, Alcohol, and Diabetes. In a similar study conducted by Pranay Wal et al. ...
5
Dosage Individualization of Anti Microbials and Cardiovascular Drugs in Patients with Chronic Renal Dysfunction
... dose adjustment was taken into account or not when prescribing drugs in patients with renal impairment. A retrospective chart review was performed and included 98 adult in-patients, diagnosed with renal impairment ...
87
Cardiovascular drugs attenuated myocardial resistance against ischaemia- induced and reperfusion-induced injury in a rat model of repetitive occlusion
... Patients with CAD most frequently are treated with antianginal or antihypertensive drugs. However, little is known whether and how these medications interact with cardioprotective signal pathways and myocardial ...
8
Practice characteristics and prescribing of cardiovascular drugs in areas with higher risk of CHD in Scotland: cross-sectional study
... This study shows that South Asians tend to be registered with practices with lower prescribing rates, but it would appear that all patients in these practices are at greater risk of having lower prescribing rates. ...
7
Thermal Decomposition of Some Cardiovascular Drugs (Telmisartane, Cilazapril and Terazosin HCL)
... Thermal analysis of some antihypertensive drugs, Telmisartan, Cilazapril and Terazosin HCL was achieved. Thermo- gravimetry, derivative thermogravimetry and differential thermal analysis were used through the ...
6
Cardiovascular Drugs and Therapies ANTICOAGULANTS (Oral) Terms and Conditions
... This information in this Handbook is intended for use by and with experienced physicians and pharmacists. The information is not intended to replace sound professional judgment in individual situations, and should be ...
14
Cardiovascular Drugs and Therapies ANTICOAGULANTS (Oral) Terms and Conditions
... This information in this Handbook is intended for use by and with experienced physicians and pharmacists. The information is not intended to replace sound professional judgment in individual situations, and should be ...
12
Zebrafish-based small molecule screens for novel cardiovascular drugs
... forward mutagenesis screen [12], suffers 2:1 AV block caused by QT prolongation induced by a mutation in the potassium channel KCNH2. Visual assessment of the embryos was used to assess whether this AV block was reversed ...
16
Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review
... Much of the pharmacokinetic research was conducted on healthy young adults; thus this evidence may not be applicable to populations with CVD and particularly for older patients taking CV drugs, due to possible ...
16
Review on Quantification of Some Selected Cardiovascular Drugs and Their Metabolites in Pharmaceuticals
... Amiodarone Hydrochloride (AD) is a potent III antiarrhythmic drug and is chemically known as 2-butyl-3-benzofuranyl4-2-(diethyl amino)ethoxy-3,5-diidophenyl methanone hydrochloride. It is used to treat ventricular and ...
9